IL6 and non-small cell lung carcinoma: To further confirm the clinical value of IL6 in NSCLC-BM, we collected peripheral blood samples from 120 NSCLC patients without BM (Supplementary Table S2) and evaluated the feasibility of predicting BM by IL6 level in serum.